Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Luminex Corp (LMNX) Common Stock

Sell:$22.58 Buy:$22.59 Change: $0.72 (3.29%)
NASDAQ:0.64%
Market closed |  Prices as at close on 27 October 2020 | Switch to live prices |
Sell:$22.58
Buy:$22.59
Change: $0.72 (3.29%)
Market closed |  Prices as at close on 27 October 2020 | Switch to live prices |
Sell:$22.58
Buy:$22.59
Change: $0.72 (3.29%)
Market closed |  Prices as at close on 27 October 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company's products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease segments. The Company has a range of instruments using its xMAP technology, which includes its LUMINEX 100/200 systems offer 100-plex testing; the Company's FLEXMAP 3D system is its high-throughput, 500-plex testing system, and its MAGPIX system provides 50-plex testing using imaging rather than flow cytometry. By using its xMAP technology, the end users are able to generate multiple simultaneous results per sample. The Company primarily serves the diagnostics, pharmaceutical and life sciences industries by marketing products, including its testing equipment and assays, to a range of testing laboratories.

Contact details

Address:
12212 Technology Blvd, 512-219-8020
AUSTIN
78727
United States
Telephone:
+1 (512) 2494741
Website:
www.luminexcorp.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
LMNX
ISIN:
US55027E1029
Market cap:
$1.01 billion
Shares in issue:
46.36 million
Sector:
Life Sciences Tools & Services
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Nachum Shamir
    President, Chief Executive Officer, Director
  • Harriss Currie
    Chief Financial Officer, Senior Vice President - Finance, Treasurer
  • Richard Rew
    Senior Vice President, General Counsel and Corporate Secretary
  • Todd Bennett
    Senior Vice President - Global Sales and Customer Operations
  • Chuck Collins
    Senior Vice President - Research and Development
  • Nancy Fairchild
    Senior Vice President - Human Resources
  • Randall Myers
    Senior Vice President - Global Manufacturing and Quality
  • Eric Shapiro
    Senior Vice President - Global Marketing

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.